Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization
- 1 February 2005
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 112 (2) , 301-304
- https://doi.org/10.1016/j.ophtha.2004.08.012
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1American Journal of Ophthalmology, 2003
- Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularizationOphthalmology, 2003
- VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal NeovascularizationThe Journal of Experimental Medicine, 2003
- Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injectionOphthalmology, 2003
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2000
- Exudative macular degeneration and intravitreal triamcinolone A pilot studyAustralian and New Zealand Journal of Ophthalmology, 1995
- The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularizationAlbrecht von Graefes Archiv für Ophthalmologie, 1993
- Macrophages related to Bruch's membrane in age-related macular degenerationEye, 1990
- Effects of Intravitreal Administration of Steroids on Experimental Subretinal Neovascularization in the Subhuman PrimateArchives of Ophthalmology (1950), 1985